[1] |
HE Lihua, ZHU Xiuzhi, JIANG Yizhou.
Research progress on immunotherapy for triple-negative breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 842-853.
|
[2] |
FU Xiaoyu, KONG Deguang, LI Juanjuan.
Treatment progress of triple positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
|
[3] |
CHEN Manxin, ZHANG Bingyu, DAI Min.
Clinical efficacy of intracoronally targeted recombinant human urokinase combined with percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) with high thrombus burden
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 544-549.
|
[4] |
HUANG Xiaoming, DU Ye, LIN Shaoming, SHEN Guanle.
Exploratory study of the influence of respiratory microbiology on the efficacy of PD-1 inhibitors monotherapy for patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 66-74.
|
[5] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[6] |
ZHOU Guangchen, LIU Yixi, ZHENG Yun.
Colorectal cancer and microRNA: research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 575-587.
|
[7] |
LU Chenyu, YANG Jun, LIU Yixi, ZHENG Yun.
Function and regulation of miRNAs associated with Parkinson's disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 775-783.
|
[8] |
CHE Jinjing.
Application of biomarkers in clinical development of biologics and bioanalytical strategies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 22-31.
|
[9] |
GAO Yuanfeng, LI Shan, LIU Lin, OUYANG Rong.
Research progress of abnormally expressed lncRNAs in glioma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 586-591.
|
[10] |
HUANG Ji-han, WANG Kun, XU Ling, HE Ying-chun, LI Lu-jin, YANG Juan, SHENG Yu-cheng, ZHENG Qing-shan.
Biomarker finding of individual salviol B exposures in healthy subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(5): 510-516.
|
[11] |
ZHANG Jin-bo, ZHANG Xiao-le, XU Guo-bin, DONG Zhi-bing, LI Chuan-guang, WANG Wen-long.
Neutrophil gelatinase-associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury following adult cardiothoracic surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1305-1309.
|
[12] |
GUAN En-ze, ZHU Xuan-xuan, WANG Guang-ji, HAO Hai-ping, DING Yang.
Metabonomics technology and its applications in disease diagnosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(1): 11-15.
|
[13] |
REN Hong-can, WANG Cuang-ji, A Ji-ye, HAO Hai-ping, SUN Jian-guo, ZHA Wei-bin, YAN Bei.
Advances of analysis technology and data processing in metabonomics study
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1332-1338.
|